• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种可选择和可切除的标记系统,用于快速创建重组痘病毒。

A selectable and excisable marker system for the rapid creation of recombinant poxviruses.

机构信息

Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, Canada.

出版信息

PLoS One. 2011;6(9):e24643. doi: 10.1371/journal.pone.0024643. Epub 2011 Sep 8.

DOI:10.1371/journal.pone.0024643
PMID:21931792
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3169633/
Abstract

BACKGROUND

Genetic manipulation of poxvirus genomes through attenuation, or insertion of therapeutic genes has led to a number of vector candidates for the treatment of a variety of human diseases. The development of recombinant poxviruses often involves the genomic insertion of a selectable marker for purification and selection purposes. The use of marker genes however inevitably results in a vector that contains unwanted genetic information of no therapeutic value.

METHODOLOGY/PRINCIPAL FINDINGS: Here we describe an improved strategy that allows for the creation of marker-free recombinant poxviruses of any species. The Selectable and Excisable Marker (SEM) system incorporates a unique fusion marker gene for the efficient selection of poxvirus recombinants and the Cre/loxP system to facilitate the subsequent removal of the marker. We have defined and characterized this new methodological tool by insertion of a foreign gene into vaccinia virus, with the subsequent removal of the selectable marker. We then analyzed the importance of loxP orientation during Cre recombination, and show that the SEM system can be used to introduce site-specific deletions or inversions into the viral genome. Finally, we demonstrate that the SEM strategy is amenable to other poxviruses, as demonstrated here with the creation of an ectromelia virus recombinant lacking the EVM002 gene.

CONCLUSION/SIGNIFICANCE: The system described here thus provides a faster, simpler and more efficient means to create clinic-ready recombinant poxviruses for therapeutic gene therapy applications.

摘要

背景

通过衰减或插入治疗基因对痘病毒基因组进行遗传操作,已经产生了许多用于治疗各种人类疾病的载体候选物。重组痘病毒的开发通常涉及选择标记的基因组插入,以用于纯化和选择目的。然而,标记基因的使用不可避免地导致载体中含有无治疗价值的不需要的遗传信息。

方法/主要发现:在这里,我们描述了一种改进的策略,可用于创建任何物种的无标记重组痘病毒。可选择和可切除标记(SEM)系统包含一个独特的融合标记基因,用于有效选择痘病毒重组体,以及 Cre/loxP 系统,以方便随后去除标记。我们通过将外源基因插入痘苗病毒来定义和表征这个新的方法工具,随后去除选择标记。然后,我们分析了 Cre 重组过程中loxP 取向的重要性,并表明 SEM 系统可用于在病毒基因组中引入特异性缺失或反转。最后,我们证明 SEM 策略适用于其他痘病毒,如在这里创建的缺乏 EVM002 基因的疱疹病毒重组体所示。

结论/意义:因此,这里描述的系统为创建用于治疗基因治疗应用的临床就绪的重组痘病毒提供了更快、更简单和更有效的方法。

相似文献

1
A selectable and excisable marker system for the rapid creation of recombinant poxviruses.一种可选择和可切除的标记系统,用于快速创建重组痘病毒。
PLoS One. 2011;6(9):e24643. doi: 10.1371/journal.pone.0024643. Epub 2011 Sep 8.
2
Recombinant Poxviruses: Versatile Tools for Immunological Assays.重组痘病毒:用于免疫测定的多功能工具。
Methods Mol Biol. 2019;1988:217-248. doi: 10.1007/978-1-4939-9450-2_16.
3
Mutant loxP vectors for selectable marker recycle and conditional knock-outs.用于选择标记回收和条件性基因敲除的突变型loxP载体。
BMC Biotechnol. 2001;1:7. doi: 10.1186/1472-6750-1-7. Epub 2001 Sep 26.
4
Rapid Generation of Multiple Loci-Engineered Marker-free Poxvirus and Characterization of a Clinical-Grade Oncolytic Vaccinia Virus.多基因工程无标记痘病毒的快速构建及临床级溶瘤痘苗病毒的特性研究
Mol Ther Methods Clin Dev. 2017 Sep 30;7:112-122. doi: 10.1016/j.omtm.2017.09.007. eCollection 2017 Dec 15.
5
Poxviruses as Gene Therapy Vectors: Generating Poxviral Vectors Expressing Therapeutic Transgenes.痘病毒作为基因治疗载体:构建表达治疗性转基因的痘病毒载体
Methods Mol Biol. 2019;1937:189-209. doi: 10.1007/978-1-4939-9065-8_11.
6
Multiple-cloning-site plasmids for the rapid construction of recombinant poxviruses.用于快速构建重组痘病毒的多克隆位点质粒。
Gene. 1985;35(1-2):169-77. doi: 10.1016/0378-1119(85)90169-6.
7
Prospects and limitations of recombinant poxviruses for prostate cancer immunotherapy.重组痘病毒用于前列腺癌免疫治疗的前景与局限性
Curr Opin Mol Ther. 1999 Aug;1(4):471-9.
8
Tools for the targeted genetic modification of poxvirus genomes.用于痘病毒基因组靶向遗传修饰的工具。
Curr Opin Virol. 2020 Oct;44:183-190. doi: 10.1016/j.coviro.2020.10.006. Epub 2020 Nov 23.
9
Construction of recombinant fowlpox viruses as vectors for poultry vaccines.构建重组禽痘病毒作为家禽疫苗载体
Virus Res. 1988 Jun;10(4):343-56. doi: 10.1016/0168-1702(88)90075-5.
10
Recombinant poxviruses: versatile tools for immunological assays.重组痘病毒:用于免疫测定的多功能工具。
Methods Mol Biol. 2013;960:219-245. doi: 10.1007/978-1-62703-218-6_18.

引用本文的文献

1
Oncolytic vaccinia virus immunotherapy antagonizes image-guided radiotherapy in mouse mammary tumor models.溶瘤痘苗病毒免疫疗法拮抗小鼠乳腺肿瘤模型的图像引导放疗。
PLoS One. 2024 Mar 18;19(3):e0298437. doi: 10.1371/journal.pone.0298437. eCollection 2024.
2
Rendezvous with Vaccinia Virus in the Post-smallpox Era: R&D Advances.在后天花时代与牛痘病毒的相会:研发进展。
Viruses. 2023 Aug 15;15(8):1742. doi: 10.3390/v15081742.
3
Poxvirus Recombination.痘病毒重组

本文引用的文献

1
Vaccinia virus-encoded ribonucleotide reductase subunits are differentially required for replication and pathogenesis.痘苗病毒编码的核糖核苷酸还原酶亚基对复制和发病机制有不同的要求。
PLoS Pathog. 2010 Jul 8;6(7):e1000984. doi: 10.1371/journal.ppat.1000984.
2
Potent oncolytic activity of raccoonpox virus in the absence of natural pathogenicity.浣熊痘病毒在无天然致病性的情况下具有强大的溶瘤活性。
Mol Ther. 2010 May;18(5):896-902. doi: 10.1038/mt.2010.14. Epub 2010 Feb 16.
3
Overall survival analysis of a phase II randomized controlled trial of a Poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate cancer.
Pathogens. 2022 Aug 9;11(8):896. doi: 10.3390/pathogens11080896.
4
The mismatched nucleotides encoded in vaccinia virus flip-and-flop hairpin telomeres serve an essential role in virion maturation.痘苗病毒翻转-反转发夹端粒中编码的不匹配核苷酸在病毒成熟中起重要作用。
PLoS Pathog. 2022 Mar 15;18(3):e1010392. doi: 10.1371/journal.ppat.1010392. eCollection 2022 Mar.
5
Vaccinia Virus Gene Acquisition through Nonhomologous Recombination.牛痘病毒通过非同源重组获得基因。
J Virol. 2021 Jun 24;95(14):e0031821. doi: 10.1128/JVI.00318-21.
6
Engineering Oncolytic Vaccinia Virus to redirect Macrophages to Tumor Cells.工程化溶瘤痘苗病毒以将巨噬细胞重定向至肿瘤细胞。
Adv Cell Gene Ther. 2021 Apr;4(2). doi: 10.1002/acg2.99. Epub 2020 Jul 3.
7
Viral Delivery of CAR Targets to Solid Tumors Enables Effective Cell Therapy.将嵌合抗原受体(CAR)靶点通过病毒递送至实体瘤可实现有效的细胞治疗。
Mol Ther Oncolytics. 2020 Apr 7;17:232-240. doi: 10.1016/j.omto.2020.03.018. eCollection 2020 Jun 26.
8
EPPIC (Efficient Purification by Parental Inducer Constraint) Platform for Rapid Generation of Recombinant Vaccinia Viruses.用于快速生成重组痘苗病毒的EPPIC(通过亲本诱导剂限制进行高效纯化)平台
Mol Ther Methods Clin Dev. 2020 Mar 30;17:731-738. doi: 10.1016/j.omtm.2020.03.026. eCollection 2020 Jun 12.
9
Engineering and Characterization of Oncolytic Vaccinia Virus Expressing Truncated Herpes Simplex Virus Thymidine Kinase.表达截短型单纯疱疹病毒胸苷激酶的溶瘤痘苗病毒的工程改造与特性分析
Cancers (Basel). 2020 Jan 17;12(1):228. doi: 10.3390/cancers12010228.
10
Genes A27L and F13L as Genetic Markers for the Isolation of Recombinant Vaccinia Virus.A27L 和 F13L 基因作为分离重组痘苗病毒的遗传标记。
Sci Rep. 2019 Oct 30;9(1):15684. doi: 10.1038/s41598-019-52053-4.
基于痘病毒的 PSA 靶向免疫治疗转移性去势抵抗性前列腺癌的 II 期随机对照试验的总生存分析。
J Clin Oncol. 2010 Mar 1;28(7):1099-105. doi: 10.1200/JCO.2009.25.0597. Epub 2010 Jan 25.
4
Myxoma virus virotherapy for glioma in immunocompetent animal models: optimizing administration routes and synergy with rapamycin.纤溶酶原病毒溶瘤疗法治疗免疫活性动物模型中的神经胶质瘤:优化给药途径和与雷帕霉素的协同作用。
Cancer Res. 2010 Jan 15;70(2):598-608. doi: 10.1158/0008-5472.CAN-09-1510. Epub 2010 Jan 12.
5
A kinase-dead knock-in mutation in mTOR leads to early embryonic lethality and is dispensable for the immune system in heterozygous mice.mTOR中的激酶失活敲入突变导致早期胚胎致死,且对于杂合子小鼠的免疫系统而言并非必需。
BMC Immunol. 2009 May 20;10:28. doi: 10.1186/1471-2172-10-28.
6
A method for the generation of ectromelia virus (ECTV) recombinants: in vivo analysis of ECTV vCD30 deletion mutants.一种生成痘苗病毒(ECTV)重组体的方法:ECTV vCD30缺失突变体的体内分析
PLoS One. 2009;4(4):e5175. doi: 10.1371/journal.pone.0005175. Epub 2009 Apr 13.
7
The 3'-to-5' exonuclease activity of vaccinia virus DNA polymerase is essential and plays a role in promoting virus genetic recombination.痘苗病毒DNA聚合酶的3'至5'核酸外切酶活性至关重要,并在促进病毒基因重组中发挥作用。
J Virol. 2009 May;83(9):4236-50. doi: 10.1128/JVI.02255-08. Epub 2009 Feb 18.
8
Vaccinia virus DNA ligase recruits cellular topoisomerase II to sites of viral replication and assembly.痘苗病毒DNA连接酶将细胞拓扑异构酶II募集至病毒复制和组装位点。
J Virol. 2008 Jun;82(12):5922-32. doi: 10.1128/JVI.02723-07. Epub 2008 Apr 16.
9
Poxvirus cancer therapy.痘病毒癌症疗法
Recent Pat Antiinfect Drug Discov. 2006 Nov;1(3):309-21. doi: 10.2174/157489106778777592.
10
Modified vaccinia virus Ankara as a vector for suicide gene therapy.安卡拉痘苗病毒修饰株作为自杀基因治疗的载体
Cancer Gene Ther. 2008 Jan;15(1):18-28. doi: 10.1038/sj.cgt.7701098. Epub 2007 Nov 9.